Immunotherapy with artificial adjuvant vector cells: Harnessing both arms of the immune response

por Fujii, Shin-ichiro, Shimizu, Kanako
Publicado 2013

Exploiting Antitumor Immunotherapeutic Novel Strategies by Deciphering the Cross Talk between Invariant NKT Cells and Dendritic Cells

por Fujii, Shin-ichiro, Shimizu, Kanako
Publicado 2017

Identification of Neoantigens in Cancer Cells as Targets for Immunotherapy

por Okada, Masahiro, Shimizu, Kanako, Fujii, Shin-ichiro
Publicado 2022

Vaccine Designs Utilizing Invariant NKT-Licensed Antigen-Presenting Cells Provide NKT or T Cell Help for B Cell Responses

por Fujii, Shin-ichiro, Yamasaki, Satoru, Sato, Yusuke, Shimizu, Kanako
Publicado 2018

Association of cellular immunity with severity of COVID-19 from the perspective of antigen-specific memory T cell responses and cross-reactivity

por Fujii, Shin-ichiro, Yamasaki, Satoru, Iyoda, Tomonori, Shimizu, Kanako
Publicado 2022

Detection of mutant antigen-specific T cell receptors against multiple myeloma for T cell engineering

por Okada, Masahiro, Shimizu, Kanako, Nakazato, Hiroshi, Yamasaki, Satoru, Fujii, Shin-ichiro
Publicado 2023

A single immunization with cellular vaccine confers dual protection against SARS‐CoV‐2 and cancer

por Shimizu, Kanako, Ueda, Shogo, Kawamura, Masami, Satoh, Mikiko, Fujii, Shin‐ichiro
Publicado 2022

Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting Cancer

por Iyoda, Tomonori, Yamasaki, Satoru, Ueda, Shogo, Shimizu, Kanako, Fujii, Shin-ichiro
Publicado 2023

Cross-presentation of glycolipid from tumor cells loaded with α-galactosylceramide leads to potent and long-lived T cell–mediated immunity via dendritic cells

por Shimizu, Kanako, Kurosawa, Yuri, Taniguchi, Masaru, Steinman, Ralph M., Fujii, Shin-ichiro
Publicado 2007

Activation of Natural Killer T Cells by α-Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8...

por Fujii, Shin-ichiro, Shimizu, Kanako, Smith, Caroline, Bonifaz, Laura, Steinman, Ralph M.
Publicado 2003

In vivo dendritic cell targeting cellular vaccine induces CD4(+) Tfh cell-dependent antibody against influenza virus

por Yamasaki, Satoru, Shimizu, Kanako, Kometani, Kohei, Sakurai, Maki, Kawamura, Masami, Fujii, Shin-ichiro
Publicado 2016

NK and NKT Cell-Mediated Immune Surveillance against Hematological Malignancies

por Shimizu, Kanako, Iyoda, Tomonori, Yamasaki, Satoru, Kadowaki, Norimitsu, Tojo, Arinobu, Fujii, Shin-ichiro
Publicado 2020

Cancer immunotherapy using artificial adjuvant vector cells to deliver NY‐ESO‐1 antigen to dendritic cells in situ

por Fujii, Shin‐ichiro, Yamasaki, Satoru, Hanada, Kenichi, Ueda, Shogo, Kawamura, Masami, Shimizu, Kanako
Publicado 2022

Combination of cancer vaccine with CD122-biased IL-2/anti-IL-2 Ab complex shapes the stem-like effector NK and CD8(+) T cells against tumor

por Shimizu, Kanako, Ueda, Shogo, Kawamura, Masami, Aoshima, Honoka, Satoh, Mikiko, Nakabayashi, Jun, Fujii, Shin-ichiro
Publicado 2023

NKT Cells as an Ideal Anti-Tumor Immunotherapeutic

por Fujii, Shin-ichiro, Shimizu, Kanako, Okamoto, Yoshitaka, Kunii, Naoki, Nakayama, Toshinori, Motohashi, Shinichiro, Taniguchi, Masaru
Publicado 2013

Eomes transcription factor is required for the development and differentiation of invariant NKT cells

por Shimizu, Kanako, Sato, Yusuke, Kawamura, Masami, Nakazato, Hiroshi, Watanabe, Takashi, Ohara, Osamu, Fujii, Shin-ichiro
Publicado 2019

Runx-mediated regulation of CCL5 via antagonizing two enhancers influences immune cell function and anti-tumor immunity

por Seo, Wooseok, Shimizu, Kanako, Kojo, Satoshi, Okeke, Arinze, Kohwi-Shigematsu, Terumi, Fujii, Shin-ichiro, Taniuchi, Ichiro
Publicado 2020

Analysis of a Chronic Myelogenous Leukemia Patient Vaccinated with Leukemic Dendritic Cells Following Autologous Peripheral Blood Stem Cell Transplantation

por Fujii, Shin‐ichiro, Shimizu, Kanako, Fujimoto, Koji, Kiyokawa, Tetsuyuki, Shimomura, Taizo, Taniguchi, Osamu, Kinoshita, Moritoshi, Kawano, Fumio
Publicado 1999

Optimal therapeutic strategy using antigen‐containing liposomes selectively delivered to antigen‐presenting cells

por Iyoda, Tomonori, Yamasaki, Satoru, Kawamura, Masami, Ueda, Motoki, Son, Kon, Ito, Yoshihiro, Shimizu, Kanako, Fujii, Shin‐ichiro
Publicado 2019

A Reversible Defect in Natural Killer T Cell Function Characterizes the Progression of Premalignant to Malignant Multiple Myeloma

por Dhodapkar, Madhav V., Geller, Matthew D., Chang, David H., Shimizu, Kanako, Fujii, Shin-Ichiro, Dhodapkar, Kavita M., Krasovsky, Joseph
Publicado 2003